Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
PREZZO DELLE AZIONI
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionDillon & Associates Inc
Latest Disclosed Ownership2,031 shares
Latest Disclosed Value $ 311
Dillon & Associates Inc reports 7.77% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 7, 2026 - Dillon & Associates Inc filed a 13F-HR form disclosing ownership of 2,031 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $260,984 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,202 shares of Novartis AG - Depositary Receipt (Common Stock). The current value of the position is $245,751 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F Novartis AG ADS NVS 66987V109 2,031 -171 -7.77 0 0.0428
2026-02-09 2025-12-31 13F Novartis AG ADS COMM 66987V109 2,202 -25 -1.12 0 0.0393
2025-10-28 2025-09-30 13F Novartis AG ADS COMM 66987V109 2,227 -50 -2.20 0 0.0366
2025-08-05 2025-06-30 13F Novartis AG ADS COMM 66987V109 2,277 -784 -25.61 0 0.0375
2025-05-12 2025-03-31 13F Novartis AG ADS COMM 66987V109 3,061 -73 -2.33 0 0.0505
2025-02-11 2024-12-31 13F Novartis AG ADS COMM 66987V109 3,134 -100 -3.09 0 0.0422
2024-11-05 2024-09-30 13F Novartis AG ADS COMM 66987V109 3,234 -1,815 -35.95 0 0.0523
2024-08-06 2024-06-30 13F Novartis AG ADS COMM 66987V109 5,049 -274 -5.15 1 0.0778
2024-04-30 2024-03-31 13F Novartis AG ADS COMM 66987V109 5,323 -200 -3.62 1 0.0811
2024-02-08 2023-12-31 13F Novartis AG ADS COMM 66987V109 5,523 -402 -6.78 1 0.1012
2023-11-13 2023-09-30 13F Novartis AG ADS COMM 66987V109 5,925 -499 -7.77 1 0.1162
2023-08-08 2023-06-30 13F Novartis AG ADS COMM 66987V109 6,424 -80 -1.23 1 0.1194
2023-05-02 2023-03-31 13F/A-1 Novartis AG ADS COMM 66987V109 6,504 -1,865 -22.28 1 0.1187
2023-05-01 2023-03-31 13F Novartis AG ADS COMM 66987V109 8,449 80 1 0.1281
2023-02-06 2022-12-31 13F Novartis AG ADS COMM 66987V109 8,369 -80 -0.95 1 -100.00 0.1648
2022-11-08 2022-09-30 13F Novartis AG ADS COMM 66987V109 8,449 0 0.00 642 -10.58 0.1489
2022-07-26 2022-06-30 13F Novartis AG ADS COMM 66987V109 8,449 0 0.00 718 -3.49 0.1618
2022-05-06 2022-03-31 13F Novartis AG ADS COMM 66987V109 8,449 0 0.00 744 1.22 0.1411
2022-02-14 2021-12-31 13F Novartis AG ADS COMM 66987V109 8,449 0 0.00 735 6.06 0.1281
2021-10-28 2021-09-30 13F Novartis AG ADS COMM 66987V109 8,449 0 0.00 693 -9.88 0.1327
2021-08-02 2021-06-30 13F Novartis AG ADS COMM 66987V109 8,449 0 0.00 769 7.10 0.1506
2021-05-10 2021-03-31 13F Novartis AG ADS COMM 66987V109 8,449 -50 -0.59 718 -10.14 0.1533
2021-02-12 2020-12-31 13F Novartis AG ADS COMM 66987V109 8,499 -190 -2.19 799 5.69 0.1735
2020-11-06 2020-09-30 13F Novartis AG ADS COMM 66987V109 8,689 0 0.00 756 0.00 0.1823
2020-07-28 2020-06-30 13F Novartis AG ADS COMM 66987V109 8,689 0 0.00 756 6.18 0.2046
2020-05-07 2020-03-31 13F Novartis AG ADS COMM 66987V109 8,689 -250 -2.80 712 -16.14 0.2397
2020-02-03 2019-12-31 13F Novartis AG ADS COMM 66987V109 8,939 190 2.17 849 11.56 0.2375
2019-10-25 2019-09-30 13F Novartis AG ADS COMM 66987V109 8,749 -13 -0.15 761 -4.52 0.2316
2019-07-22 2019-06-30 13F Novartis AG ADS COMM 66987V109 8,762 25 0.29 797 -5.01 0.2464
2019-05-07 2019-03-31 13F Novartis AG ADS COMM 66987V109 8,737 -350 -3.85 839 7.43 0.2725
2019-02-14 2018-12-31 13F Novartis AG ADS COMM 66987V109 9,087 0 0.00 781 0.00 0.2974
2018-11-14 2018-09-30 13F Novartis AG ADS COMM 66987V109 9,087 -25 -0.27 781 12.70 0.2585
2018-08-08 2018-06-30 13F Novartis AG ADS COMM 66987V109 9,112 -1,350 -12.90 693 -18.18 0.2558
2018-05-08 2018-03-31 13F Novartis AG ADS COMM 66987V109 10,462 -250 -2.33 847 -5.89 0.3272
2018-02-08 2017-12-31 13F Novartis AG ADS COMM 66987V109 10,712 0 0.00 900 -2.28 0.3393
2017-11-13 2017-09-30 13F Novartis AG ADS COMM 66987V109 10,712 -25 -0.23 921 3.37 0.3633
2017-08-09 2017-06-30 13F Novartis AG ADS COMM 66987V109 10,737 -453 -4.05 891 7.61 0.3672
2017-04-26 2017-03-31 13F Novartis AG ADS COMM 66987V109 11,190 -80 -0.71 828 0.61 0.3525
2017-02-02 2016-12-31 13F Novartis AG ADS COMM 66987V109 11,270 -1,242 -9.93 823 -16.70 0.3741
2016-10-31 2016-09-30 13F Novartis AG ADS COMM 66987V109 12,512 -2,300 -15.53 988 -19.61 0.4558
2016-08-12 2016-06-30 13F Novartis AG ADS COMM 66987V109 14,812 -3,905 -20.86 1,229 -8.83 0.5644
2016-05-03 2016-03-31 13F Novartis AG ADS COMM 66987V109 18,717 -910 -4.64 1,348 -20.14 0.6252
2016-01-25 2015-12-31 13F Novartis AG ADS COMM 66987V109 19,627 -1,848 -8.61 1,688 -14.57 0.8161
2015-10-29 2015-09-30 13F Novartis AG ADS COMM 66987V109 21,475 -85 -0.39 1,976 -6.48 0.9886
2015-08-07 2015-06-30 13F Novartis AG ADS COMM 66987V109 21,560 104 0.48 2,113 -0.52 1.0295
2015-04-24 2015-03-31 13F Novartis AG ADS COMM 66987V109 21,456 425 2.02 2,124 8.59 1.0194
2015-02-11 2014-12-31 13F Novartis AG ADS COMM 66987V109 21,031 338 1.63 1,956 0.57 0.9502
2014-11-13 2014-09-30 13F Novartis AG ADS COMM 66987V109 20,693 379 1.87 1,945 5.25 0.9916
2014-08-14 2014-06-30 13F Novartis AG ADS COMM 66987V109 20,314 -241 -1.17 1,848 5.78 0.9475
2014-05-14 2014-03-31 13F Novartis AG ADS COMM 66987V109 20,555 106 0.52 1,747 6.78 0.9343
2014-02-11 2013-12-31 13F Novartis AG ADS COMM 66987V109 20,449 -150 -0.73 1,636 0.55 0.8828
2013-11-13 2013-09-30 13F Novartis AG ADS COMM 66987V109 20,599 -357 -1.70 1,627 9.34 0.9092
2013-08-09 2013-06-30 13F Novartis AG ADS COMM 66987V109 20,956 20,956 1,488 0.9531
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.